• Successful Early Lamotrigine and Aripiprazole Augmentation of Clomipramine in Severe Obsessive-compu...

• Seo Eun-Hyun

• Kim Seung-Gon, Lee Jae-Hon, Yoon Hyung-Jun

• Clinical Psychopharmacology and Neuroscience   2023  Volume.21  No.3 604 ~ 608

• Potential Effect of Vortioxetine on Restless Leg Syndrome

• Yasemin Hosgoren Alici

• Muge Kuzu Kumcu

• Clinical Psychopharmacology and Neuroscience   2023  Volume.21  No.3 599 ~ 603

• Additional Clinical Benefit of Agomelatine Treatment for Major Depressive Disorder in Naturalistic T...

• Lee Kyung-Ho

• Han Tae-Sun, Han Chang-Su, Bahk Won-Myong, Lee Soo-Jung, Ashwin A. Patkar, Prakash S. Masand,&n...

• Clinical Psychopharmacology and Neuroscience   2023  Volume.21  No.3 594 ~ 598

• Clinical Implication of Maumgyeol Basic Service?the 2 Channel Electroencephalography and a Photoplet...

• Lee Seung-Hwan

• Hwang Hyeon-Ho, Kim Sung-Kean, Hwang Jun-Seok, Park Jae-Hyun, Park Sang-Shin

• Clinical Psychopharmacology and Neuroscience   2023  Volume.21  No.3 583 ~ 593

• Oxidative Stress and Inflammatory Biomarkers in People with Methamphetamine Use Disorder

• Cetin Turan

• Guliz Senormanci, Salim Neselioglu, Yasemin Budak, Ozcan Erel, Omer Senormanci

• Clinical Psychopharmacology and Neuroscience   2023  Volume.21  No.3 572 ~ 582

• Effects of Parental Verbal Abuse Experience on the Glutamate Response to Swear Words in the Ventrome...

• Yoo Jae-Hyun

• Park Young-Woo, Kim Do-Hyun, Park Hyun-Wook, Jeong Bum-Seok

• Clinical Psychopharmacology and Neuroscience   2023  Volume.21  No.3 559 ~ 571

• Treatment Retention Rates of 3-monthly Paliperidone Palmitate and Risk Factors Associated with Disco...

• Chien-Heng Lin

• Huang-Li Lin, Lee Hye-Won, Yi-Wen Chen, Yan-Fang Liu, Yen-Kuang Yang, Chao-Hsiun Tang

• Clinical Psychopharmacology and Neuroscience   2023  Volume.21  No.3 544 ~ 558

• Drug-drug Interaction between Psychotropic Medications and Medications Used in COVID-19: Comparison ...

• Surobhi Chatterjee

• Sujita Kumar Kar, Aathira Jaya Prakash, Teena Bansal, Garima Singh

• Clinical Psychopharmacology and Neuroscience   2023  Volume.21  No.3 534 ~ 543

• Evaluation of Atherosclerotic Risk by Oxidative Contributors in Alcohol Use Disorder

• Almila Senat

• Esra Kabadayi-Sahin, Ibrahim Sogut, Tomris Duymaz, Ozcan Erel

• Clinical Psychopharmacology and Neuroscience   2023  Volume.21  No.3 526 ~ 533

• Arterial Stiffness in Patients with Bipolar Disorder

• Asli Kazgan Kilicaslan

• Burcu Sirlier Emir, Sevler Yildiz, Gulhan Kilicaslan, Osman Kurt

• Clinical Psychopharmacology and Neuroscience   2023  Volume.21  No.3 516 ~ 525

• Oxytocin Levels in Children with Separation Anxiety and Their Mothers before and after Treatment

• Nur Seda Gulcu Ustun

• Sefika Nur Gumus, Nusret Soylu

• Clinical Psychopharmacology and Neuroscience   2023  Volume.21  No.3 499 ~ 515

• The Outcome of Antipsychotics-induced Tardive Syndromes: A Ten-year Follow-up Study

• Pei-Chien Chou

• Yu Lee, Yung-Yee Chang, Pao-Yen Lin, Liang-Jen Wang

• Clinical Psychopharmacology and Neuroscience   2023  Volume.21  No.3 488 ~ 498

• Which Severe Mental Illnesses Most Increase the Risk of Developing Dementia? Comparing the Risk of D...

• Wei Hung Chang

• Chien-Chou Su, Kao Chin Chen, Yin Ying Hsiao, Po See Chen, Yen Kuang Yang

• Clinical Psychopharmacology and Neuroscience   2023  Volume.21  No.3 478 ~ 487

• A Randomized Clinical Trial to Assess the Effect of Medication Therapy Plus tDCS on Problem-solving ...

• Parnaz Mardani

• Hossein Javdani, Ahmad Zolghadriha, Xi Xie, Mohsen Dadashi

• Clinical Psychopharmacology and Neuroscience   2023  Volume.21  No.3 466 ~ 477

• Does Post-traumatic Stress Disorder Impact Treatment Outcomes within a Randomised Controlled Trial o...

• Samantha E. Russell

• Anna L. Wrobel, Melanie M. Ashton, Alyna Turner, Mohammadreza Mohebbi, Michael Berk, Sue Cotton...

• Clinical Psychopharmacology and Neuroscience   2023  Volume.21  No.3 457 ~ 465

• Development of a Guideline for Antipsychotic-induced Hyperprolactinemia in Korea Using the ADAPTE Pr...

• Kim Hye-Ri

• Takayoshi Uematsu, Kang Won-Sub, Jeon Hong-Jun, Jang Seung-Ho, Jon Duk-In, Hong Jeong-Wan, ...

• Clinical Psychopharmacology and Neuroscience   2023  Volume.21  No.3 447 ~ 456

• The Role of Glutamate Underlying Treatment-resistant Depression

• Kim Jeong-Seop

• Kim Tae-Eun, Lee Seung-Hwan, Koo Ja-Wook

• Clinical Psychopharmacology and Neuroscience   2023  Volume.21  No.3 429 ~ 446

• The Link between Suicidality and Electroencephalography Asymmetry: A Systematic Review and Meta-anal...

• Laine B. Butler

• Kate B. Nooner

• Clinical Psychopharmacology and Neuroscience   2023  Volume.21  No.3 419 ~ 428

• The Impact of COVID-19 on Psychiatric Health in the Korean Population

• Wang Sheng-Min

• Kim Sung-Hwan, Choi Won-Seok, Lim Hyun-Kook, Woo Young-Sup, Pae Chi-Un, Bahk Won-Myong

• Clinical Psychopharmacology and Neuroscience   2023  Volume.21  No.3 410 ~ 418

• Anhedonia and Depressive Disorders

• Alessandro Serretti

• Clinical Psychopharmacology and Neuroscience   2023  Volume.21  No.3 401 ~ 409